Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,019,706
+$8,526,567 QoQ
Shares Held
190,827
+5.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#377
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$17,770
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $338,415,690 across 14 Drug Manufacturers - General names. ABBV ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
336,570 | $85,478,682 | |
| 2 | LLY |
ELI LILLY & Co
|
59,006 | $70,773,572 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
190,827 | $48,019,706 | |
| 4 | MRK |
Merck & Co., Inc.
|
271,475 | $34,884,537 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
417,663 | $24,065,742 | |
| 6 | AMGN |
Amgen Inc
|
47,883 | $17,339,391 | |
| 7 | NVS |
Novartis AG
|
104,792 | $16,423,002 | |
| 8 | PFE |
Pfizer Inc
|
634,638 | $15,282,083 |
All Filings in ABBV
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,019,706 | 190,827 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,493,139 | 181,586 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,910,778 | 183,425 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,852,896 | 172,121 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $33,702,652 | 181,568 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $43,799,736 | 209,048 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $48,086,686 | 270,606 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $17,770 | 100 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $19,748 | 100 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $67,711,743 | 342,879 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,152 | 100 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $57,715,450 | 336,494 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $52,915,163 | 290,583 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $32,733,228 | 211,223 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,855,997 | 227,130 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,632,684 | 212,519 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $4,041,900 | 30,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $8,728,854 | 54,771 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,859,664 | 61,009 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,530,925 | 56,113 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,275,522 | 60,561 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,425,237 | 58,141 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,995,427 | 81,207 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,719,483 | 53,022 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,985,559 | 44,261 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,107,598 | 37,956 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,143,138 | 29,334 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,898,002 | 33,086 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,334,781 | 33,966 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $5,237,224 | 68,739 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||